EJ
Eric Joseph JP Morgan Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
12
Avg Return
Past Year
Past Year
8.4%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
75%
Neutral
16.7%
Negative
8.3%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Materials
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Materials
Chemicals
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Upgraded
| $11 |
218%
upside
| 1 | -18% |
0
%
| 17 Dec ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $49 |
67%
upside
| 1 | -16% |
0
%
| 3 Nov ‘25 4 months ago |
|
|
|
Overweight
Maintained
| $46 |
71%
upside
| 1 | -0.59% |
0
%
| 9 Oct ‘25 5 months ago |
|
|
|
Overweight
Maintained
| $64 |
26%
downside
| 2 | +71% |
0
%
| 3 Jun ‘25 9 months ago |
|
|
|
Neutral
Downgraded
| – | – | 1 | – |
–
| 20 May ‘25 9 months ago |
|
|
|
Overweight
Maintained
| $44 |
740%
upside
| 1 | -26% |
0
%
| 9 May ‘25 10 months ago |
|
|
|
Underweight
Maintained
| $7 |
34%
downside
| 1 | -60% |
0
%
| 9 May ‘25 10 months ago |
|
|
|
Overweight
Maintained
| $67 |
3%
downside
| 3 | +20% |
0
%
| 7 May ‘25 10 months ago |
|
|
|
Neutral
Initiated
| – | – | 1 | – |
–
| 25 Apr ‘25 10 months ago |
|